Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 25, 2015 07:00 ET | Source: EPIRUS Biopharmaceuticals, Inc.

EPIRUS Biopharmaceuticals to Host Biosimilar Key Opinion Leader Meeting and Webcast on March 30

BOSTON, March 25, 2015 (GLOBE NEWSWIRE) -- EPIRUS Biopharmaceuticals, Inc. (Nasdaq:EPRS), a Boston-based biopharmaceutical company focused on the global development of biosimilar monoclonal...
March 23, 2015 16:35 ET | Source: EPIRUS Biopharmaceuticals, Inc.

EPIRUS Reports Fourth Quarter and Fiscal Year 2014 Financial Results

BOSTON, March 23, 2015 (GLOBE NEWSWIRE) -- EPIRUS Biopharmaceuticals, Inc. (Nasdaq:EPRS), a Boston-based biopharmaceutical company focused on the global development of biosimilar monoclonal...
March 11, 2015 07:00 ET | Source: EPIRUS Biopharmaceuticals, Inc.

EPIRUS to Report Fourth Quarter and Fiscal Year 2014 Financial Results on March 24, 2015

BOSTON, March 11, 2015 (GLOBE NEWSWIRE) -- EPIRUS Biopharmaceuticals, Inc. (Nasdaq:EPRS), a Boston-based biopharmaceutical company focused on the global development of biosimilar monoclonal...